Ebiox Q3 Trading Update
November 26 2009 - 1:00AM
UK Regulatory
TIDMHCEG
RNS Number : 0979D
Healthcare Enterprise Group PLC
26 November 2009
26 November 2009
Healthcare Enterprise Group PLC
("Healthcare Enterprise" or the "Group")
Ebiox announces sales growth of 53% in Q3 and launch of new products
Healthcare Enterprise (AIM: HCEG), an international healthcare group, is pleased
to announce that Ebiox Limited, in which it holds a 20% interest, has reported
sales growth of 53% in the three months to September 2009, as compared to the
same period last year, following a GBP800,000 cash injection by private
investors, including Nigel Wray.
The July to September 09 quarter was the first under Ebiox' new management,
headed by John Honey, formerly Senior VP at Reckitt Benckiser plc.
Highlights:
* Sales up 53% on the same period last year following revenue growth of hand &
surface cleaning products
* Launch of new biodegradable, macerator-friendly, hard surface antimicrobial wipe
* Pipeline of new products includes a non alcohol-based sanitising foam hand rub
The new Trionic D biodegradable wipes contain the same proven Ebiox Trionic
formulation to clean and disinfect medical devices and hard surfaces, removing
biofilms and providing a broad efficacy in removing and killing harmful
pathogens. They use a high wet strength cellulose fibre sheet which is fully
biodegradable and can be disposed of after use through a macerator unit within a
Hospital sluice room thus avoiding the need to dispose of within a clinical
waste stream.
Great Ormond Street Hospital has just completed a successful six month trial of
the disinfectant wipes and Ebiox is currently engaged in discussions with other
potential customers, while also seeking to extend the use of the Ebiox Trionic
formulation to other healthcare and hygiene applications.
Ebiox Esense is a non alcohol based hand rub. The product has a broad range
antimicrobial efficacy and is fully compliant to the required European efficacy
standards for hygienic hand rubs used in medical environments. The formulation
is also Chlorhexidine and Triclosan free and encourages frequent use so as to
protect users against potential cross contamination issues and as a defense in
many situations arising from public places.
Lyndon Gaborit, Executive Deputy Chairman of Healthcare Enterprise, commented:
"We are delighted with the sales growth announced by Ebiox today. Whilst we have
seen some increased demand as a result of concerns about swine flu, Ebiox has
under its dedicated new management and with additional funding, displayed strong
growth and is developing a solid pipeline of new products."
For further information, please contact:
+-----------------------------------------+------------------------------+
| Healthcare Enterprise Group PLC | Tel: 020 7680 3649 |
| Lyndon Gaborit | |
| | |
+-----------------------------------------+------------------------------+
| Ebiox | Tel: 077 2054 9177 |
| John Honey | |
| | |
+-----------------------------------------+------------------------------+
| PD Marketing | Tel: 014 527 71065 |
| Dan Dullaghan | |
| | |
+-----------------------------------------+------------------------------+
| Bishopsgate Communications | Tel: 020 7562 3355 |
| Robyn Samuelson / Giang Nguyen | |
| | |
+-----------------------------------------+------------------------------+
Note to Editors
Healthcare Enterprise
Healthcare Enterprise Group PLC (HCEG) is a healthcare investment group which
invests in synergistic products and services within the healthcare industry. It
currently has two main investments:
* Ebiox Limited - Patented decontamination and disinfectant products that are safe
and alcohol free but substantially more effective than conventional methods at
destroying embedded microorganisms. The Ebiox range includes hand hygiene
products, surface disinfectants and products to clean and decontaminate surgical
instruments. HCEG owns 20% of Ebiox Limited.
* Reproductive Sciences Limited - Innovative slow release pump for intrauterine
insemination, proven to significantly enhance pregnancy success rates. HCEG owns
27% of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTFEAFMISUSEIF
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Healthcare Ent. (London Stock Exchange): 0 recent articles
More Healthcare Enterprise News Articles